NDC Crossover 64725-2220 Lantus

View and Compare Similar Products, Alternatives & Options

NDC Crossover of Similar Products Matching

The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.

Explore similar products to 64725-2220 – Lantus, . This list includes other cross-matching products that share:

The same product name: Lantus
OR Generic name:
AND the same Administration Route:
OR Dosage Form:

This list of related drugs for easy comparison is ideal for healthcare professionals, pharmacists, and patients looking for alternative or substitute products.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0088-2219	Lantus Solostar	Insulin Glargine	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0088-2220	Lantus	Insulin Glargine	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0088-5020	Lantus Solostar	Insulin Glargine	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0088-5021	Lantus	Insulin Glargine	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0955-1728	Insulin Glargine Solostar	Insulin Glargine	Injection, Solution	Subcutaneous	Winthrop U.s.	Human Prescription Drug
0955-1729	Insulin Glargine	Insulin Glargine	Injection, Solution	Subcutaneous	Winthrop U.s.	Human Prescription Drug
50090-0876	Lantus	Insulin Glargine	Injection, Solution	Subcutaneous	A-s Medication Solutions	Human Prescription Drug
50090-6184	Insulin Glargine	Insulin Glargine	Injection, Solution	Subcutaneous	A-s Medication Solutions	Human Prescription Drug